
Eli Lilly announced a $3 billion expansion of a manufacturing facility the drugmaker bought earlier this year in Wisconsin to ramp up production of its diabetes and weight-loss drugs.
The pharmaceutical giant said it will expand the plant in Kenosha County, Wis., adding 750 jobs to the current 100-person workforce, to meet growing demand for its popular injectable drugs, Mounjaro and Zepbound.